Airi P.
- Country
- Estonia
- Department
- N/A
Research Overview
- Efficacy, Safety, and Immunogenicity of mRNA-1647 Vaccine in Preventing Primary Cytomegalovirus Infection in CMV-Seronegative Females Aged 16-40
- An Open-Label Extension Study to Evaluate Long Term Safety and Efficacy of Tildrakizumab in Patients with Psoriatic Arthritis.
- Long-Term Safety, Tolerability, and Efficacy of Zasocitinib in Adults With Active Psoriatic Arthritis: A Phase 3 Extension Study
Data & Insights
Has run more than one trial at 247 of 538 partner sites.
Specializations
Rheumatologic Conditions
The investigator specializes in treating complex autoimmune joint disorders, with particular focus on psoriatic arthritis and rheumatoid arthritis. Their research extends to novel therapeutic approaches for axial spondyloarthritis.
- Advanced Psoriatic Arthritis Treatment
- Rheumatoid Arthritis Management
- Spondyloarthritis Therapies
Dermatological Disorders
Expertise in treating severe dermatological conditions, focusing on moderate to severe plaque psoriasis and atopic dermatitis. The investigator works with innovative biological therapies and targeted treatments.
- Plaque Psoriasis Treatment
- Atopic Dermatitis Management
- Biological Therapy Applications
Infectious Disease Prevention
Specialized in preventive medicine through vaccination studies for various conditions including pneumococcal diseases, influenza, respiratory syncytial virus, and herpes simplex.
- Vaccine Development Research
- Immunization Studies
- Viral Disease Prevention
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.